KAILEY FRIESZ: Open Payments
NPI 1205594082 · PROSSER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 31 payments from 14 companies in 2025. Trend: 2023 $727 · 2024 $1,418 · 2025 $1,067
Food & beverage: $1,016Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $318 |
| Madrigal Pharmaceuticals | 7 | $181 |
| Ardelyx, Inc. | 2 | $138 |
| GENZYME CORPORATION | 1 | $95 |
| ABBVIE INC. | 3 | $72 |
| Boston Scientific Corporation | 1 | $58 |
| Lilly USA, LLC | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Philips North America LLC | 1 | $27 |
| Braintree Laboratories, Inc. | 1 | $22 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, RINVOQ, General - Biliary Devices, OMVOH, ENTYVIO.
Industry payments across WA — which companies pay providers there.
